[Dermatologic in-patient rehabilitation of atopic dermatitis in adulthood].

J Dtsch Dermatol Ges

Asklepios-Nordseeklinik, Westerland/Sylt.

Published: March 2003

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1610-0387.2003.02513.xDOI Listing

Publication Analysis

Top Keywords

[dermatologic in-patient
4
in-patient rehabilitation
4
rehabilitation atopic
4
atopic dermatitis
4
dermatitis adulthood]
4
[dermatologic
1
rehabilitation
1
atopic
1
dermatitis
1
adulthood]
1

Similar Publications

Aim: To review the existing literature relating to nurse competence in safe medication management practices for biologics, identify evidence, and develop a competency framework to clarify the role of nurses in these practices.

Background: With the widespread use of biological agents in disease treatment, ensuring the safe and economical use of high-cost medicines is particularly important. Even though nurses are essential in patient care, detailed knowledge regarding their competence and role in the safe administration of biologics is lacking.

View Article and Find Full Text PDF

Aims: Sarcoendoplasmic reticulum Ca-ATPase 2 (SERCA2), encoded by ATP2A2, is a key protein involved in intracellular Ca homeostasis. The SERCA2a isoform is predominantly expressed in cardiomyocytes and type I myofibres. Variants in this gene are related to Darier disease, an autosomal dominant dermatologic disorder, but have never been linked to myopathy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the cost-effectiveness of budesonide/formoterol compared to other asthma treatments at Mexico's National Institute for Respiratory Diseases.
  • Budesonide/formoterol had a lower average cost per patient ($733.36 USD) compared to fluticasone/vilanterol ($767.24 USD), and it showed a significant reduction in exacerbations with an incremental cost-effectiveness ratio (ICER) of $613.31 USD for better management.
  • Overall, budesonide/formoterol was found to be a very cost-effective treatment option, suggesting it could reduce healthcare costs associated with emergency visits and hospitalizations despite fewer exacerbations per patient.
View Article and Find Full Text PDF

A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan.

Sci Rep

January 2025

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Extramammary Paget disease (EMPD) is a rare skin cancer that typically occurs in the anogenital area of older people. Since efficacy of treatments for metastatic or unresectable EMPD remains poor, development of a novel therapeutic approach is strongly desired. However, the lack of EMPD models has hampered investigation of EMPD.

View Article and Find Full Text PDF

Background: Psychodermatological conditions play an important role in dermatological practice. The biopsychosocial disease model is of central significance.

Objective: Psychodermatological knowledge is underrepresented in specialist training and medical care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!